Skip to main content

Hidradenitis Suppurativa

Hidradenitis Suppurativa

Featured

Derm Q&A
Findings from a recent study showed patients with HS have a similar incidence to other well-studied, at-risk patient groups of opioid use, including those with newly diagnosed musculoskeletal pain. Lead study author Sarah Reddy discusses the implications of these findings and the role dermatologists play in identifying patients at-risk for opioid misuse.
News
A recent study showed only 32% of patients with hidradenitis suppurativa who are overweight or obese receive weight counseling, which suggests more awareness and education about weight management and
News
A recent study identified a possible ‘window of opportunity’ for initiating adalimumab that could predict treatment response among patients with hidradenitis suppurativa.
News
Hidradenitis suppurativa (HS) is associated with lower quality of life. Findings from a recent study showed arthralgia can exacerbate this burden in patients.
News
The use of complementary and alternative medicine among patients with HS is very common, according to the findings of a recent survey, which also showed nearly 50% of patients did not find conventiona
Back to Top